ME02431B - Injektabilni superzasićeni rastvor acetaminofena za spinalnu primenu - Google Patents
Injektabilni superzasićeni rastvor acetaminofena za spinalnu primenuInfo
- Publication number
- ME02431B ME02431B MEP-2016-118A MEP2016118A ME02431B ME 02431 B ME02431 B ME 02431B ME P2016118 A MEP2016118 A ME P2016118A ME 02431 B ME02431 B ME 02431B
- Authority
- ME
- Montenegro
- Prior art keywords
- acetaminophen
- supersaturated
- aqueous solution
- use according
- local anesthetic
- Prior art date
Links
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims 34
- 229960005489 paracetamol Drugs 0.000 claims 17
- 239000007864 aqueous solution Substances 0.000 claims 12
- 239000003589 local anesthetic agent Substances 0.000 claims 9
- 230000000202 analgesic effect Effects 0.000 claims 4
- 239000000243 solution Substances 0.000 claims 4
- 239000002904 solvent Substances 0.000 claims 2
- ZKMNUMMKYBVTFN-HNNXBMFYSA-N (S)-ropivacaine Chemical compound CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C ZKMNUMMKYBVTFN-HNNXBMFYSA-N 0.000 claims 1
- LEBVLXFERQHONN-UHFFFAOYSA-N 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Chemical compound CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-UHFFFAOYSA-N 0.000 claims 1
- QTGIAADRBBLJGA-UHFFFAOYSA-N Articaine Chemical compound CCCNC(C)C(=O)NC=1C(C)=CSC=1C(=O)OC QTGIAADRBBLJGA-UHFFFAOYSA-N 0.000 claims 1
- VTUSIVBDOCDNHS-UHFFFAOYSA-N Etidocaine Chemical compound CCCN(CC)C(CC)C(=O)NC1=C(C)C=CC=C1C VTUSIVBDOCDNHS-UHFFFAOYSA-N 0.000 claims 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 claims 1
- 208000004550 Postoperative Pain Diseases 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 230000003444 anaesthetic effect Effects 0.000 claims 1
- 229960003831 articaine Drugs 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 229960003150 bupivacaine Drugs 0.000 claims 1
- 229960002023 chloroprocaine Drugs 0.000 claims 1
- VDANGULDQQJODZ-UHFFFAOYSA-N chloroprocaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1Cl VDANGULDQQJODZ-UHFFFAOYSA-N 0.000 claims 1
- 229960001747 cinchocaine Drugs 0.000 claims 1
- PUFQVTATUTYEAL-UHFFFAOYSA-N cinchocaine Chemical compound C1=CC=CC2=NC(OCCCC)=CC(C(=O)NCCN(CC)CC)=C21 PUFQVTATUTYEAL-UHFFFAOYSA-N 0.000 claims 1
- 238000007872 degassing Methods 0.000 claims 1
- 229960003976 etidocaine Drugs 0.000 claims 1
- 239000011261 inert gas Substances 0.000 claims 1
- 229960004288 levobupivacaine Drugs 0.000 claims 1
- LEBVLXFERQHONN-INIZCTEOSA-N levobupivacaine Chemical compound CCCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-INIZCTEOSA-N 0.000 claims 1
- 229960004194 lidocaine Drugs 0.000 claims 1
- 229960002409 mepivacaine Drugs 0.000 claims 1
- INWLQCZOYSRPNW-UHFFFAOYSA-N mepivacaine Chemical compound CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C INWLQCZOYSRPNW-UHFFFAOYSA-N 0.000 claims 1
- 229960003502 oxybuprocaine Drugs 0.000 claims 1
- CMHHMUWAYWTMGS-UHFFFAOYSA-N oxybuprocaine Chemical compound CCCCOC1=CC(C(=O)OCCN(CC)CC)=CC=C1N CMHHMUWAYWTMGS-UHFFFAOYSA-N 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- 229960001807 prilocaine Drugs 0.000 claims 1
- MVFGUOIZUNYYSO-UHFFFAOYSA-N prilocaine Chemical compound CCCNC(C)C(=O)NC1=CC=CC=C1C MVFGUOIZUNYYSO-UHFFFAOYSA-N 0.000 claims 1
- -1 proximethacaine Chemical compound 0.000 claims 1
- 229960001549 ropivacaine Drugs 0.000 claims 1
- 229960002372 tetracaine Drugs 0.000 claims 1
- GKCBAIGFKIBETG-UHFFFAOYSA-N tetracaine Chemical compound CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 GKCBAIGFKIBETG-UHFFFAOYSA-N 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0085—Brain, e.g. brain implants; Spinal cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Emergency Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Anesthesiology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Claims (11)
1. Stabilni superzasićeni injektabilni vodeni rastvor acetaminofena za analgetičku upotrebu spinalnom primenom pri čemu navedeni superzasićeni injektabilni vodeni rastvor sadrži rastvarač koji je degaziran ili značajno bez kiseonika ili vazduha i sadrži acetaminofen u koncentraciji većoj od 1.8 tež./zapr.
2. Superzasićeni injektabilni vodeni rastvor acetaminofena za upotrebu prema patentnom zahtevu 1 gde je koncentracija acetaminofena u opsegu od 1.8 do 8.0 % tež./zapr.
3. Superzasićeni injektabilni vodeni rastvor acetaminofena za upotrebu prema patentnom zahtevu 1 ili 2 gde je navedeni injektabilni vodeni rastvor značajno bez konzervanasa, i/ili aditiva i/ili ko-rastvarača.
4. Superzasićeni injektabilni vodeni rastvor acetaminofena za upotrebu prema patentnom zahtevu 1, dobijen degaziranjem vode pomoću protoka inertnog gasa i pomoću rastvaranja acetaminofena u njemu u količini takvoj da se dobije superzasićeni rastvor.
5. Superzasićeni vodeni rastvor acetaminofena za upotrebu prema bilo kom od patentnih zahteva 1-4 u lečenju post-hirurškog bola.
6. Superzasićeni vodeni rastvor acetaminofena za upotrebu prema bilo kom od patentnih zahteva 1-4 koji sadrži istovremenu, posebnu ili uzastopnu spinalnu primenu sa lokalnim anestetikom.
7. Superzasićeni vodeni rastvor acetaminofena za upotrebu prema patentnom zahtevu 6 gde se rastvor acetaminofena dodaje u ili meša sa rastvorom lokalnog anestetika za spinalnu primenu.
8. Superzasićeni vodeni rastvor acetaminofena za upotrebu prema patentnom zahtevu 6 ili 7 gde je navedeni lokalni anestetik - lokalni anestetik sa kratkim dejstvom izabran od lidokaina, artikaina, oksibuprokaina, hloroprokaina ili lokalni anestetik srednje dužine dejstva izabran od prilokaina, mepivakaina, etidokaina ili lokalni anestetik sa dugim dejstvom izabran od ropivakaina, bupivakaina, cinhokaina, levobupivakaina, proksimetakaina, tetrakaina.
9. Superzasićeni vodeni rastvor acetaminofena za upotrebu prema patentnom zahtevu 6 za kombinovani analgetički-anestetički tretman.
10. Superzasićeni vodeni rastvor acetaminofena za upotrebu prema patentnom zahtevu 6 gde analgetički efekat acetaminofena ima duže trajanje od analgetičkog efekta lokalnog anestetika.
11. Superzasićeni vodeni rastvor acetaminofena za upotrebu prema patentnom zahtevu 6 gde lokalni anestetik i acetaminofen ispoljavaju analgetički efekat čak posle kraja anestetičkog efekta izazvanog lokalnim anestetikom.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT001154A ITMI20121154A1 (it) | 2012-06-29 | 2012-06-29 | Soluzione iniettabile di acetaminofene per la somministrazione spinale |
| EP13765450.5A EP2874602B1 (en) | 2012-06-29 | 2013-06-27 | Injectable supersaturated acetaminophen solution for spinal administration |
| PCT/IB2013/055277 WO2014002042A1 (en) | 2012-06-29 | 2013-06-27 | Injectable supersaturated acetaminophen solution for spinal administration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ME02431B true ME02431B (me) | 2016-09-20 |
Family
ID=46690603
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-2016-118A ME02431B (me) | 2012-06-29 | 2013-06-27 | Injektabilni superzasićeni rastvor acetaminofena za spinalnu primenu |
Country Status (44)
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0646400B1 (en) * | 1993-04-14 | 2001-07-18 | Nippon Sanso Corporation | Dissolved oxygen reducing apparatus |
| US6171298B1 (en) * | 1996-05-03 | 2001-01-09 | Situs Corporation | Intravesical infuser |
| FR2751875B1 (fr) | 1996-08-05 | 1998-12-24 | Scr Newpharm | Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation |
| FR2809619B1 (fr) | 2000-06-06 | 2004-09-24 | Pharmatop | Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention |
| DE10112325A1 (de) * | 2001-03-13 | 2002-10-02 | Fresenius Kabi De Gmbh | Lagerstabile Fertiginfusionslösungen des Paracetamols |
| CN1582170B (zh) * | 2001-12-18 | 2010-05-05 | 联合制药克伦茨蒂斯药物实验室公司 | 扑热息痛的肠胃外组合物 |
| FR2851164B1 (fr) * | 2003-02-14 | 2005-04-22 | Xuan Tho Nguyen | Formulation liquide injectable de paracetamol |
| DE102005037653A1 (de) * | 2005-08-05 | 2007-02-15 | Theraselect Gmbh | Stabile, flüssige Formulierung von Paracetamol |
| WO2008009756A1 (es) * | 2006-07-18 | 2008-01-24 | Genfarma Laboratorio S.L. | Formulación líquida inyectable de paracetamol |
| CN101015542A (zh) * | 2007-02-13 | 2007-08-15 | 天津生机集团有限公司 | 家畜用复方对乙酰氨基酚注射液及其制备方法 |
| MD3528G2 (ro) * | 2007-09-28 | 2008-11-30 | Сергей ШАНДРУ | Metodă de anestezie spinală continuă la pacienţii în etate |
| CA2705733C (en) * | 2007-11-13 | 2015-02-03 | Cadence Pharmaceuticals | Reduced dose intravenous acetaminophen |
| US20110015273A1 (en) | 2008-01-17 | 2011-01-20 | Rajnarayana Kandhagatla | Stable pharmaceutical aqueous compositions |
| WO2009143558A1 (en) * | 2008-05-26 | 2009-12-03 | Silphion Pty Limited | Injectable formulations |
| EP2243477A1 (de) | 2009-04-22 | 2010-10-27 | Fresenius Kabi Deutschland GmbH | Paracetamol zur parenteralen Verabreichung |
| JP2013006770A (ja) * | 2009-10-09 | 2013-01-10 | Ssp Co Ltd | アセトアミノフェン含有経口液剤 |
| WO2012001494A2 (en) * | 2010-06-30 | 2012-01-05 | Troikaa Pharmaceuticals Limited | Pharmaceutical compositions comprising paracetamol and process for preparing the same |
-
2012
- 2012-06-29 IT IT001154A patent/ITMI20121154A1/it unknown
-
2013
- 2013-06-27 MD MDA20140138A patent/MD4537C1/ro not_active IP Right Cessation
- 2013-06-27 JP JP2015519450A patent/JP5876620B2/ja not_active Expired - Fee Related
- 2013-06-27 UA UAA201413899A patent/UA117101C2/uk unknown
- 2013-06-27 CA CA2876801A patent/CA2876801C/en active Active
- 2013-06-27 BR BR112014032818-8A patent/BR112014032818B1/pt not_active IP Right Cessation
- 2013-06-27 KR KR1020147036909A patent/KR102118227B1/ko not_active Expired - Fee Related
- 2013-06-27 PE PE2014002536A patent/PE20150331A1/es active IP Right Grant
- 2013-06-27 PL PL13765450.5T patent/PL2874602T3/pl unknown
- 2013-06-27 DK DK13765450.5T patent/DK2874602T3/en active
- 2013-06-27 PT PT137654505T patent/PT2874602T/pt unknown
- 2013-06-27 EA EA201500065A patent/EA028909B1/ru unknown
- 2013-06-27 WO PCT/IB2013/055277 patent/WO2014002042A1/en not_active Ceased
- 2013-06-27 ES ES13765450.5T patent/ES2578012T3/es active Active
- 2013-06-27 US US14/411,532 patent/US11344517B2/en active Active
- 2013-06-27 GE GEAP201313679A patent/GEP201706689B/en unknown
- 2013-06-27 AU AU2013282753A patent/AU2013282753B2/en not_active Ceased
- 2013-06-27 CN CN201380034500.0A patent/CN104487051B/zh not_active Expired - Fee Related
- 2013-06-27 MX MX2014015402A patent/MX369264B/es active IP Right Grant
- 2013-06-27 AP AP2014008152A patent/AP2014008152A0/xx unknown
- 2013-06-27 HU HUE13765450A patent/HUE029431T2/en unknown
- 2013-06-27 MA MA37811A patent/MA37811B1/fr unknown
- 2013-06-27 SI SI201330208A patent/SI2874602T1/sl unknown
- 2013-06-27 EP EP13765450.5A patent/EP2874602B1/en active Active
- 2013-06-27 SG SG11201408479WA patent/SG11201408479WA/en unknown
- 2013-06-27 SG SG10201704482YA patent/SG10201704482YA/en unknown
- 2013-06-27 ME MEP-2016-118A patent/ME02431B/me unknown
- 2013-06-27 HR HRP20160706TT patent/HRP20160706T1/hr unknown
- 2013-06-27 MY MYPI2014703994A patent/MY169251A/en unknown
- 2013-06-27 RS RS20160435A patent/RS54844B1/sr unknown
- 2013-06-27 NZ NZ703829A patent/NZ703829A/en not_active IP Right Cessation
- 2013-06-28 AR ARP130102331 patent/AR091633A1/es unknown
-
2014
- 2014-12-18 NI NI201400147A patent/NI201400147A/es unknown
- 2014-12-18 TN TN2014000526A patent/TN2014000526A1/fr unknown
- 2014-12-22 ZA ZA2014/09478A patent/ZA201409478B/en unknown
- 2014-12-23 IL IL236423A patent/IL236423A/en active IP Right Grant
- 2014-12-26 CU CUP2014000150A patent/CU20140150A7/es unknown
- 2014-12-26 CL CL2014003536A patent/CL2014003536A1/es unknown
- 2014-12-29 DO DO2014000302A patent/DOP2014000302A/es unknown
-
2015
- 2015-01-08 EC ECIEPI2015500A patent/ECSP15000500A/es unknown
- 2015-01-27 CR CR20150036A patent/CR20150036A/es unknown
- 2015-01-27 PH PH12015500178A patent/PH12015500178B1/en unknown
- 2015-01-27 CO CO15015754A patent/CO7240357A2/es unknown
-
2016
- 2016-01-19 US US15/001,064 patent/US20160128955A1/en not_active Abandoned
- 2016-06-28 CY CY20161100584T patent/CY1117691T1/el unknown
- 2016-07-26 SM SM201600248T patent/SMT201600248B/it unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA111834C2 (uk) | Лікарська форма | |
| BR112014029757A2 (pt) | composição contendo tensoativos do tipo aminoácido, betaínas e n-metil-n-acilglucaminas e tendo qualidade de espuma melhorada e maior viscosidade | |
| AR085128A1 (es) | Composicion de acido hialuronico | |
| BR112014029758A2 (pt) | composição contendo n-metil-n-acilglucamina | |
| EA201101603A1 (ru) | Гиперразветвленные поликарбонаты для солюбилизации труднорастворимых действующих веществ | |
| RU2015141767A (ru) | Композиции и способы для местной доставки простагландинов в подкожный жир | |
| MX382569B (es) | Compuesto de carboxamida, sulfonamida y amina para trastornos metabolicos. | |
| SMT201400081B (it) | Composizioni farmaceutiche di clevidipina e metodiper produrre concentrazioni di questa con un bass o livello di impurezze | |
| BRPI0607379A2 (pt) | métodos de usar como analgésicos 1-benzil-1-hidroxi-2,3-diamino-propil aminas, amidas de ácido 3-benzil-3-hidroxi-2-amino-propiÈnico e compostos relacionados | |
| BR112016007522A2 (pt) | painéis de gesso usando uma proporção elevada de água-estuque | |
| UA113962C2 (xx) | Фармацевтична композиція, яка містить апоморфін як активний інгредієнт | |
| UA105425C2 (ru) | Кристаллическая форма агомелатина гидрохлорида гидрата и способ ее получения | |
| EP3274548A4 (en) | METHOD AND COMPOSITIONS FOR INJECTING HIGHLY CONCENTRATED AND / OR HIGH VISICULAR ACTIVE SOLUTIONS | |
| AR091039A1 (es) | Composiciones farmaceuticas topicas que comprenden terbinafina, uso y metodo de tratamiento | |
| EP3526295A4 (en) | INSECT REPELLENT AND ICE REPELLING COMPOSITIONS WITH LIQUID ADDITIVES | |
| MY180534A (en) | Liquid composition for oral use and method for improving resilience to freezing thereof | |
| HRP20160706T1 (hr) | Injektabilna prezasićena otopina acetaminofena za spinalnu primjenu | |
| MY166444A (en) | Mixed crystal agomelatine (form-viii), preparation method and use thereof and pharmaceutical composition containing same | |
| SG11201804619PA (en) | Hair cosmetic | |
| GEAP201813784A (en) | Stabilised amorphous form of agomelatine, a process for its preparation and pharmaceutical compositions containing it | |
| CN103756454A (zh) | 一种高性能净味墙面漆 | |
| IN2014DE00467A (me) | ||
| WO2014140899A3 (en) | Morphine sulfate methanolic solvate, processes for making same and related compositions and methods for treating pain | |
| EP3491937A4 (en) | LIQUID SEASONING AGENT WITH SOLID INGREDIENTS | |
| EP3386501C0 (de) | Analgetische zusammensetzungen mit nanocarriern und ihre verwendung |